Skip to main content

and
  1. No Access

    Article

    Preservation of renal perfusion and postoperative renal function by side-to-side cavo-caval anastomosis in liver transplant recipients

    Postoperative renal failure is common after liver transplantation (LT). The aim of this study was to investigate peroperative renal perfusion and postoperative renal function in 12 patients who underwent LT wi...

    François Durand, Jean Aschehoug, Alain Sauvanet in Transplant International (1995)

  2. No Access

    Article

    Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin

    The HMG-CoA reductase inhibitor, lovastatin, is known to induce asymptomatic liver dysfunction in a few patients. We report the case of an adult who suffered from clinical hepatitis three months after the onse...

    Sylvie Grimbert, Dominique Pessayre, Claude Degott in Digestive Diseases and Sciences (1994)

  3. No Access

    Chapter and Conference Paper

    Chronic Non-A, Non-B, Non-C Hepatitis in French Blood Donors Assessed with HCV Third-generation Tests and Polymerase Chain Reaction

    The livers of blood donors with increased serum aminotransferase levels were assessed histologically and were tested for antibodies to hepatitis C virus (anti-HCV) with a third-generation ELISA and RIBA and fo...

    Dr. Patrick Marcellin, Michèle Martinot-Peignoux in Viral Hepatitis and Liver Disease (1994)

  4. No Access

    Chapter and Conference Paper

    Long-term Histologic Improvement and Persistent HCV Replication in Patients with Chronic Hepatitis C Having Responded to Recombinant Alpha Interferon

    We assessed long-term outcome in 24 patients with chronic hepatitis C who responded to interferon-α in a previous study. All patients were followed up for 12 months and 16 patients were followed up for a furth...

    Dr. Patrick Marcellin, Nathalie Boyer in Viral Hepatitis and Liver Disease (1994)

  5. No Access

    Article

    MR imaging in intracystic hemorrhage of simple hepatic cysts

    Intracystic hemorrhage of simple hepatic cysts is one of the most frequent complications. Ul-trasonography (US) and computed tomography (CT) may show abnormal findings and mimic other diseases. We describe mag...

    Valérie Vilgrain, Olivia Silbermann, Jean-Pierre Benhamou, Henri Nahum in Abdominal Imaging (1993)

  6. No Access

    Article

    Compte rendu de congrès

    G. Angelvin-Bonnety, F. Arnold-Richez, G. Bardelay, M. C. Baughon in Acta Endoscopica (1992)

  7. No Access

    Chapter

    Transient Portal Hypertension

    In most cases, portal hypertension is a chronic complication of a chronic disease of the portal vein, or the liver, or the hepatic veins. It is conceivable that an acute and transient disease of the portal vei...

    Jean-Pierre Benhamou in Portal Hypertension (1991)

  8. No Access

    Chapter

    Prevention of the First Gastrointestinal Bleeding

    Esophageal variceal bleeding may occur in patients with portal hypertension who have developed superior portosystemic circulation. Thus, the ideal way to prevent bleeding esophageal varices is to avoid the dev...

    Didier Lebrec, Jean-Pierre Benhamou in Portal Hypertension (1991)

  9. No Access

    Chapter

    Disorders of the Hepatic Veins and Venules

    Impaired outflow of blood from the liver commonly results from diseases affecting the hepatic venous tree. “Hepatic venous outflow block” is the best term for designating these diseases. The terms “Chiari’s di...

    Jean-Pierre Benhamou, Dominique Valla in Portal Hypertension (1991)

  10. No Access

    Chapter

    Pulmonary Arterial Hypertension in Patients with Portal Hypertension

    A rare exception to the usual systemic, splanchnic, and pulmonary vasodilation in patients with portal hypertension is the occurrence of pulmonary hypertension. In the lung, the most frequent change associated...

    Antoine Hadengue, Didier Lebrec, Jean-Pierre Benhamou in Portal Hypertension (1991)

  11. No Access

    Chapter

    Clinical Manifestations of Portal Hypertension

    Portal hypertension, like systemic arterial hypertension, may be clinically latent and is usually diagnosed under three circumstances. First, in patients with chronic liver disease, clinical evaluation, ultras...

    Antoine Hadengue, Didier Lebrec, Jean-Pierre Benhamou in Portal Hypertension (1991)

  12. No Access

    Article

    Pharmacokinetics of Ketanserin in Patients with Cirrhosis

    The pharmacokinetics of ketanserin, a new serotonin S2 (5HT2) antagonist, were studied in 26 patients with cirrhosis. Patients were randomised to receive either a single oral dose of ketanserin 20mg (n = 14) or 4...

    Dr Didier Lebrec, Antoine Hadengue, Christophe Gaudin in Clinical Pharmacokinetics (1990)

  13. No Access

    Article

    A Randomised Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis

    74 cirrhotic patients with a history of variceal or gastric bleeding were randomly assigned to treatment with propranolol (40 to 360 mg/day) or placebo. The patients were all in good condition and doses of pro...

    Dr Didier Lebrec, Thierry Poynard, Jacques Bernuau, Eric Bercoff, Olivier Nouel in Drugs (1989)